Showing results (181-190 of 261) with videos related to
Sort By:
Pageof 27
Scientific Reports|August 5, 2017
SERS Investigation of Cancer Cells Treated with PDT: Quantification of Cell Survival and Follow-upA B Veloso, J P F Longo, L A Muehlmann, et al.Journal of Biomedical Nanotechnology|April 21, 2012
Aluminum-chloride-phthalocyanine encapsulated in liposomes: activity against naturally occurring dog breast cancer cellsMartha S T Rocha, Carolina M Lucci, João Paulo F Longo, et al.Gut|August 13, 2002
Fatigue is associated with high circulating leptin levels in chronic hepatitis CT Piche, E Gelsi, S M Schneider, et al.Scientific Reports|January 19, 2019
Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry diseaseSimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.Clinical Radiology|March 5, 2017
Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival ratesB Sacconi, M Anzidei, A Leonardi, et al.Orphanet Journal of Rare Diseases|January 30, 2020
Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and painSimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 23, 2020
Determinants of cerebral radiological progression in Fabry diseaseSimon Körver, Maria G F Longo, Marjana R Lima, et al.Nanomedicine (London, England)|November 8, 2017
DNA methylation alterations induced by transient exposure of MCF-7 cells to maghemite nanoparticlesRaphael S Bonadio, Ana Carolina Arcanjo, Emilia Cd Lima, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 22, 2010
Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRIV Cantisani, P Ricci, M Erturk, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working PartyG D'Arena, C G Valentini, G Pietrantuono, et al.Pageof 27